Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Angiodynamics (ANGO) Long-Term Debt Issuances (2014 - 2025)

Angiodynamics posted quarterly Long-Term Debt Issuances of -$6.3 million for Q2 2025, down 109.01% on a QoQ basis from $70.0 million in Q3 2022.

Angiodynamics (ANGO) has 6 years of Long-Term Debt Issuances data on file, last reported at -$6.3 million in Q2 2025.

  • For the quarter ending Q2 2025, Long-Term Debt Issuances changed N/A year-over-year to -$6.3 million; the trailing twelve-month figure through May 2025 stood at -$6.3 million (changed N/A YoY), and the FY2023 full-year result was $70.0 million, up 1300.0% from the prior year.
  • Long-Term Debt Issuances for Q2 2025 stood at -$6.3 million, down from $70.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $70.0 million in Q3 2022 and bottomed at -$6.3 million in Q2 2025.
  • The 3-year median for Long-Term Debt Issuances is $5.0 million (2021), against an average of $22.9 million.
  • Peak annual rise in Long-Term Debt Issuances reached 1300.0% in 2022, while the deepest fall reached 1300.0% in 2022.
  • A 3-year view of Long-Term Debt Issuances shows it stood at $5.0 million in 2021, then soared by 1300.0% to $70.0 million in 2022, then slumped by 109.01% to -$6.3 million in 2025.
  • The last three Long-Term Debt Issuances figures came in at -$6.3 million (Q2 2025), $70.0 million (Q3 2022), and $5.0 million (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 46.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 875.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 5.04 Mn
10 Angiodynamics 497.07 Mn 459.26 Mn 41.48 Mn -

Historic Data

Download Data 🔒
DateValue
May 31, 2025 -6.31 Mn
May 31, 2025 -6.31 Mn
Aug 31, 2022 70.00 Mn
Aug 31, 2022 70.00 Mn
Aug 31, 2021 5.00 Mn
Aug 31, 2021 5.00 Mn
May 31, 2020 25.00 Mn
May 31, 2020 25.00 Mn
Feb 29, 2020 15.00 Mn
Feb 29, 2020 15.00 Mn
May 31, 2017 -116.47 Mn
May 31, 2017 -116.47 Mn
May 31, 2014 5.00 Mn
May 31, 2014 5.00 Mn
Feb 28, 2014 41.41 Mn
Feb 28, 2014 41.41 Mn